Morphological features of liver injury in COVID-19 according to data of own histological and literary research

  • Received 29.12.2021

  • Revised 25.01.2022

  • Accepted 23.02.2022



  • 799 Views

  • Retrieved from Volume 3, No. 4, 2021

  • Pages 182-185

Summary. SARS-CoV-2 infection is highly pathogenic and tropic to tissues of various internal organs. Severe course of COVID-19 is often accompanied by multiple organ failure, including liver damage. Therefore, the study of the morphogenesis features of liver tissue is an urgent task, because hepatocyte dysfunction is registered with a high frequency and the severity of the disease is associated with the degree of liver damage. The aim of the study – to investigate the pathomorphological features of liver damage in COVID-19. Materials and Methods. Scientific literature and histological studies of liver tissues of 4 patients, who died from complications of SARS-CoV-2 infection in hospitals of Ternopil region, were analyzed. Results. It was prooved, that severe course of SARS-CoV-2 infection is accompanied by multiple organ failure, including dystrophic, inflammatory and ischemic liver damage. Conclusion. Liver damage in severe course of COVID-19 manifests as significant macrovesicular steatosis, hepatocyte necrosis, lymphomacrophage infiltration of the portal tracts, and venous plethora in the vascular bed. These changes are the result of multiorgan inflammation, hypoxia, systemic inflammatory reactions, comorbidities that cause liver dysfunction and hepatotoxic effects of certain drugs

COVID-19, liver damage, hepatocytes steatosis

https://doi.org/10.11603/bmbr.2706-6290.2021.4.12777

[1] Cao,  X.  COVID-19:  immunopathology  and  its implications for therapy. Nat Rev Immunol. 2020;20: 269-70. Available from: https://doi.org/10.1038/s41577-020-0308-3

[2] Arno R Bourgonje, Amaal E Abdulle, Wim Timens, Jan-Luuk Hillebrands, Gerjan J Navis, Sanne J Gordijn et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and  the  pathophysiology  of  coronavirus  disease  2019 (COVID-19). J Pathol 2020; 251(3): 228-48. Available from: https://doi.org/10.1002/path.5471

[3] Hoffman  M.  SARS-CoV-2  cell  entry  depends  on ACE2 and TMPRSS2 and is blocked by a clinically proven protease  inhibitor.  Cell.  2020.  Available  from:  https://doi.org/10.1016/j.cell.2020.02.052

[4] Sufang Tian, Yong Xiong, Huan Liu, Li Niu, Jianchun Guo,  Meiyan  Liao  et  al.  Pathological  study  of  the  2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Pathol. 2020;33(6): 1007-14. Available from: https://doi.org/10.1038/s41379-020-0536-x

[5] Komisarenko SV. [Hunting of scientists for coronavirus SARS-COV-2,   which   causes   COVID-19:   scientific strategies for overcoming the pandemic]. Visn NAN Ukrainy. 2020;8:  29-71.  Available  from:  https://doi.org/10.15407/visn2020.08.029. Ukrainian.

[6] Fadieienko GD, Nikiforova YaV. [Tropism COVID-19 to  the  digestive  system.  Features  of  the  lesion  and approaches to treatment]. Such hastroenterol. 2020; 4(114): 65-72. Available from: https://doi.org/10.30978/MG-2020-4-65. Ukrainian.